Clinical trials

15

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

To Determine the Effect of Phaseolean on Glycemic Response to Carbohydrate Rich Meal in Healthy Adult Human Participants

This is an Open-Label, Randomized, Three-Way, Three-Arm, Crossover, Balance Study to Evaluate the Effect of Phaseolean on Glycemic response to carbohydrate rich meals in Healthy Adult Participants Using an In Vivo Method.

Participants needed: 12
Trial details
Age: 18-45Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Mar 25, 2026
Eligibility criteria

Participant has any known food allergy or intolerance to any food or beverages. [+11]

Status: Not yet recruiting

Validation of Skin Instrumentation to Detect Ceramide-Driven Lipid Replenishment - Assessing Skin Glow, Hydration, Trans Epidermal Water Loss, Skin Surface Assessment, Sebum and Least-Reflection Factor.

This is a single-center, open-label, split-face, site-randomized validation study, NB250045-NB-V designed to establish and confirm the reliability, reproducibility, and sensitivity of various skin measurement methods. Evaluator blinding will be implemented to minimize observer bias.

Participants needed: 15
Trial details
Age: 18-55Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Feb 20, 2026
Eligibility criteria

1) Age: 18 to 55 years old (both inclusive) at the time of consent. 2) Sex: Heal...

1) History of any dermatological condition of the skin diseases. 2) Subject with...

Status: Recruiting

Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus Patients

This is a Proof-of-Science, exploratory, prospective, single-treatment, two-group, clinical safety, efficacy and tolerability study of herbal based Sugar support effervescent tablets on the patients with Type 2 Diabetes Mellitus.

Participants needed: 14
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Feb 5, 2026Locations: 1
Eligibility criteria

1) Male and female individuals with the age between 18 to 65 years at the time o...

1) Subjects diagnosed with other types of Diabetes like T1DM or specific type of...

Status: Not yet recruiting

Exploratory Clinical Investigation on Neurosensory Responses Via EEG Headband in Adults With Mild to Moderate Atopic Dermatitis After Application of Marketed Product Compared With Placebo (Water Application).

This is a prospective, exploratory, double-blind, single-visit internal validation study designed to evaluate neurosensory responses using electroencephalography head band (EEG) in adult subjects with mild to moderate atopic dermatitis (AD) following a single topical application of marketed product compared with placebo (water application).

Participants needed: 20
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Jan 12, 2026
Eligibility criteria

Age: 18 to 65 years (both inclusive) at the time of consent having mild to moder...

History of any dermatological condition of the skin diseases. 2. Subject with pr...

Status: Not yet recruiting

Clinical Study to Assess Safety, Effectiveness and In-Use Tolerability of Saffron Extract Capsules for Improving Skin Health and Reducing Signs of Aging on Healthy Adult Male and Female Subjects.

This is a randomized, double-blind, comparative, two-arm, prospective, interventional, multi-centre clinical study to evaluate the safety, efficacy, and in-use tolerability of test products, standardized saffron extract capsules, on skin rejuvenation and age-defying benefits in healthy adult male and female subjects.

Participants needed: 50
Trial details
Age: 30-55Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Jan 7, 2026
Eligibility criteria

Age: 30 to 55 years (both inclusive) at the time of consent. [+8]

Subjects who are on steroids for last six months and using immunosuppressive, an... [+11]

Status: Not yet recruiting

Clinical Safety and Efficacy Study of Water Flosser in Enhancing Oral Health Among Healthy Adults Having Plaque-induced Gingivitis and Dental Plaque Accumulation

This is a double-blind, randomized, control-arm clinical study to evaluate safety and efficacy of test water flosser in enhancing oral health among healthy adults having plaque-induced gingivitis and dental plaque accumulation.

Participants needed: 64
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Nov 10, 2025
Eligibility criteria

Age: 18 to 65 years (both inclusive) old at the time of consent. [+12]

Subjects who are undergoing treatment for gingivitis, caries, dental plaque and... [+17]

Status: Not yet recruiting

Dermatological Safety and Skin Compatibility Evaluation of Test Products

Dermatological Safety and Skin Compatibility Evaluation of Test Product following Cosmetics Europe: Product Test Guidelines for Assessment of Human Skin Compatibility (Colipa Standard, 1997)

Participants needed: 26
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Sep 29, 2025
Eligibility criteria

Age: 18-65 years (both inclusive) at the time of consent. [+11]

Subject having skin irritation, blemishes, excessive hair, moles, pigmentation,... [+12]

Status: Not yet recruiting

To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects

To Check Dermatological Safety of Test Products by 24 Hours Patch Testing

Participants needed: 26
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Aug 8, 2025
Eligibility criteria

Age: 18-65 years (both inclusive) at the time of consent. [+13]

Subject having skin irritation, blemishes, excessive hair, moles, pigmentation,... [+14]

Status: Not yet recruiting

To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects.

To Check Dermatological Safety of Test Products by 24 Hours Patch Testing

Participants needed: 26
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Aug 8, 2025
Eligibility criteria

Subject scoring greater than 30 for Section 2 - Sensitive v/s Resistant skin in... [+1]

Subject having skin irritation, blemishes, excessive hair, moles, pigmentation,... [+1]

Status: Not yet recruiting

Clinical Study to Assess the Safety and Efficacy of ACV Moringa Effervescent Tablet Intake on Weight Management in Overweight and Class I Obese Study Participants

A Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Single-Centre, Clinical Study to Evaluate the Safety and Efficacy of Intake of ACV Moringa on the Degree of Weight Change in Overweight and Class I Obese Study Participants

Participants needed: 66
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Aug 1, 2025
Eligibility criteria

Age: 18- 65 years (both inclusive) at the time of consent. [+17]

Subjects BMI is between less than 25 and greater than 35 kg/m2. [+22]

Status: Not yet recruiting

A Clinical Study to Determine the Safety and Efficacy of An Oral Probiotic Supplementation in the Management of Irritable Bowel Syndrome With Protein Digestion.

This is an open-label, two-arm, prospective, interventional, in-use safety and efficacy study of an oral probiotic supplementation in adult subjects having irritable bowel syndrome.

Participants needed: 18
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Nov 14, 2024
Eligibility criteria

The subject is an adult male or female aged between 18 to 60 years old. [+5]

The subject has a history of diagnosis of either hypertension, diabetes, or live... [+9]

Status: Not yet recruiting

A Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients.

This is an exploratory, proof-of-concept, double-blind, placebo-controlled, randomized, comparative, interventional, prospective, safety in-use tolerability and efficacy study of test products in patients with mild to moderate Atopic Dermatitis.

Participants needed: 44
Trial details
Age: 6-65Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Nov 13, 2024
Eligibility criteria

1) Age: For children: 6 years and above (both inclusive) at the time of parental...

1)Subjects with AD on the scalp (with hair), palms, and soles. 2) Subjects with...

Status: Not yet recruiting

Proof-of-Science, Prospective, Interventional, Three-arm, Double-Blind, Randomized, Safety and Efficacy Real World Evidence Study.

This is proof-of-science, prospective, interventional, three-arm, double-blind, randomized, safety and efficacy real world evidence study of herbal and non herbal formulations in healthy human subjects having complaint of hair fall and pre-mature graying.

Participants needed: 99
Trial details
Age: 18-55Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Aug 13, 2024
Eligibility criteria

Age: 18 to 55 years and above (both inclusive) at the time of consent. [+15]

Subject have history of severe hair fall due to any clinically significant probl... [+11]

Status: Not yet recruiting

A Clinical Study to Assess Safety, Efficacy and In-use Tolerability of Different Dosages of Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III).

This is a prospective, interventional, exploratory, four-arm - dose response study, comparative, double-blind, randomized, placebo-control, proof of concept, safety, efficacy and in-use tolerability study of three different dosage formulation of test hair growth products and placebo in patients with mild to moderate Androgenic Alopecia (Grade I to III).

Participants needed: 72
Trial details
Age: 25-45Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Aug 13, 2024
Eligibility criteria

Age: 25 to 45 years and above (both inclusive) at the time of consent. [+13]

Patient have history of severe hair fall due to any clinically significant probl... [+11]

Status: Not yet recruiting

A Clinical Study to Determine the Safety and Efficacy of An Oral Probiotic. Supplementation in Reducing the Risk of Kidney Stone in Adults With Recurrent Kidney Stone Colic or Acute Episode of Colicky Pain.

A Preliminary Investigation of the Safety and Effectiveness of Oral Probiotics Supplementation for Reducing the Risk of Kidney Stone in Adults with Recurrent Kidney Stone Colic or Acute Episode of Colicky Pain: An Open-Label, Single-Arm, Prospective, Interventional, Proof-of-Science Study. 14 adults, with recurrent kidney stone colic or acute episode of colicky pain will be enrolled to ensure 12 subjects complete the study

Participants needed: 14
Trial details
Age: 18-55Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Jun 27, 2024
Eligibility criteria

The subject is an adult aged between 18 to 55 years old. [+8]

The subject has a history of severe renal impairment or chronic kidney disease. [+6]